U.S. court lifts block on competitor to AstraZeneca’s Nexium

LONDON (Reuters) – A U.S. court has lifted a temporary block stopping South Korea’s Hanmi Pharmaceutical from launching a close relative of AstraZeneca’s Nexium stomach-acid drug in the United States. AstraZeneca said on Wednesday that the U.S. Court of Appeals for the Federal Circuit had removed the temporary injunction on Hanmi’s esomeprazole strontium product that had been imposed last month while a legal dispute continues. …